News
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...
Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.
The White House has not yet clarified the extent of tariffs on pharmaceuticals, meanwhile, Swiss giant Roche has announced a ...
Fears of a pharmaceutical exodus are mounting in Brussels after Swiss pharma giant Roche announced a $50 billion, five-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback